Histopathological Study of Prostatic Lesions
DOI:
https://doi.org/10.70284/njirm.v10i5.2590Keywords:
Histopathological, Benign Prostatic Hyperplasia (BPH), Prostatic AdenocarcinomaAbstract
Introduction: Prostatic lesions are extremely common in elderly men over the age 50. Prostatic carcinoma is the second most common cause of cancer related deaths and its incidence has been increasing in recent years due to early screening measures. Aim: The purpose of this study is to evaluate histopathological spectrum of prostatic lesions & to correlate them with clinical features and serum PSA level. Methods: A prospective study was conducted in pathology department at Smt. N.H.L. Municipal Medical College on a total 156 prostatic specimens. All specimens were processed by paraffin embedding method and stained by Hematoxylin and Eosin stain. Results: Out of 156 prostatic lesions studied, 112 (71.79%) were benign and 44 (28.21%) were malignant. Peak incidence of both benign and malignant lesions was noted in 7th decade. Most of the patients (82%) were presented with obstructive urinary tract symptoms. Amongst benign lesions, all were found to be of benign prostatic hyperplasia (BPH). Out of 44 cases of prostatic adenocarcinomas, 43 cases were of acinar type; whereas one case was of prostatic ductal adenocarcinoma. Majority of cases with malignant lesions had S.PSA level >10 ng/ml. Gleason score 7 was observed in 45.45% of all malignant lesions. Conclusion: A histopathological examination proves to be gold standard tool for the diagnosis and prognosis of prostatic lesions. S. PSA is an important screening test for early detection of prostatic cancer. [Sabalpara M Natl J Integr Res Med, 2019; 10(5):58-63]
References
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300.
3. Gill MJ,Allepuz C, Lioja LA: A multicentric study on detection of prostate cancer by digital rectal examination and prostate specific antigen in men with or without urinary symptoms: European Urology:32;133-139,1997.
4. Mital Yadav, Hemina Desai, Hansa Goswami. Study of Various Histopathological Patterns in Prostate Biopsy. Int J Cur Res Rev:2007;9(21);58-63
5. Gaudin PB, Rosai Juan, Epstein JI.Sarcomas and related proliferative lesions of specialized Prostatic stroma: A clinicopathological study of 22 cases. Am J SurgPathol. 1998;22(2):148-162.
6. Herawi M, Epstein JI. Specialised stromal tumors of the prostate: A clinicopathologic study of 50 cases. Am J SurgPathol. 2006;30(6):694-704.
7. Wade JS, Raymond EL, Adriana OR, Peter WT, Shiming TU, Louis LP. Adult prostate sarcoma: The M.D. Anderson cancer centre experience. J Urol. 2001; 166(2):521-525.
8. Arora K, Sapre J, Agnihotri AS, et al. Utility of prostate specific antigen in different prostatic lesions, PSA assay. Pathology and Laboratory Medicine 2011;3(1):18-23.
9. Sharma P, Patel MM, Raval A, et al. Histopathological lesions in Transrectal ultrasound guided biopsies of prostate in patients with raised serum prostate specific antigen. IJSR 2014;3(11):2277-8179.
10. Ghafoori M, Varedi P, Hosseini SJ, Asgari M, Shakiba M. Value of [8]prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men. Urol J. 2009;6(3):182-88.
11. Umbehr MH, Gurel B, Murtola TJ et al. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng/ ml, normal DRE and negative for prostate cancer. Prostate Cancer Prostatic Dis 2005;18:264-9. Crossref
12. Kiehl R, Lemos LD, Stavale JN, Ortiz V. Correlation between histologic grading and serum prostatic specific antigen in prostatic carcinoma. IntUrolNephrol 1994;26:665-8. Crossref
13. Papsidero LD, Kuriyama M, Wang MC et al. Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst 1981;66:37-42. Crossref
14. Horninger W, Volgger H, Rogatsch H, Strohmeyer D, Steiner H, Hobisch A et al. Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: Results of tyrol prostate specific Antigen Screening Project. J Urol 2001; 165: 1143-1145.
15. Pacelli A, Bostwick GD. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimen. Urol 1997; 50: 355-359.
16. Choi JH, Kim JH, Park CH, Lee SC: Clinical value of prostatic biopsy in patientswith elevated serum PSA: Korean Journal of Urology,1996;37:1110-1116.
17. Kamil Cam, HakanOzveri, LeventTurkeri,AtifAkdas: The significance of hypoechoic lesion directed and transition zone biopsies in improving the diagnostic ability in prostate cancer: Brazilian Journal of Urology;27:222-226,2001.
18. Juan Rosai. Male reproductive system. Juan Rosai (editor). Juan Rosai and Ackerman`s Surgical Pathology. 11th ed, Missouri: Mosby: 2018; 1097-1134.
19. Subathra K, Sangeetha N. histopathological study of prostatic lesions and assessment with AGNOR index. Int J Pharm Bio Sci 2014;5:B253-60.
20. Deshmukh BD, Ramteerthakar NA, Sulhyan KR. Histopathological study of lesions of prostate-a five year study. Int J Health Sci Res. 2014;4:1-9.
21. Jatav J, Tomar KS, Pandit V, Iyenger S, Jain B. Characterization of prostatic lesions in surgically resected specimens. Indian J Appl Res 2015;5:444-6.
22. Babaian RJ, Grunow WA. Reliability of gleason grading system in comparing prostate biopsies with total prostatectomy specimens. Urology. 1985;25(6):564–567.
23. Falzarano SM, Navas M, Simmerman K, Klein EA, RubinMA, Zhou M. ERG rearrangements present in a subset of transition zone prostatic tumors. Modern Pathology,2010;20:1499-1506
24. Epstein JI. An update of Gleason grading system. J Urol2010;183:433-40
25. Epstein JI, Allsbrook WC Jr, Amin MB, et al. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists. Adv Anat Pathol 2003;13:57-9
26. Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla A. Tumors of the Prostate Gland, Seminal Vesicle, Male Urethra and Penis. Washington, DC: Armed Forces Institute of Pathology; 2000. Atlas of Tumor Pathology. 3rd series, fascicle 28:1-344.
27. Epstein JI. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol. 1995;26(2):223-229.
